top of page
All posts
Alzheimer's
ANVISA
Author: Allan Matsui
Author: Jairo Utimi
Author: Claudia Cilento
Author: Nilva Bortoleto
BPF
Cannabidiol
Cancer
Cannabis
Coronavirus
Covid-19
challenges
Epilepsy
pharmaceutical
IFA
pharmaceutical industry
Inovatie
medicines
opportunities
Parkinson
pharmaceuticals
pharmaceutical industry
Author: Camille Rodrigues da Silva
Incremental innovation
Investments
Marketing
News
Incremental innovation
Good Manufacturing Practices
Search
Oct 17, 2024
Anvisa publishes the list of active ingredients of medicines with registration requests under analysis
Sep 12, 2024
We must support Anvisa
Aug 30, 2024
Post-registration of medicines – opportunities and challenges
Aug 12, 2024
Clinical Research Law: A Historic Regulatory Milestone for Clinical Trial with Human Beings in Brazil
Jun 17, 2024
Anvisa's General Management of Medicines releases the 2023 Management Report
Feb 7, 2024
Find out about Anvisa's priorities for the next biennium
Nov 21, 2023
RDC 753 - New Regulatory Framework for the Registration of Synthetic Drugs.
Nov 6, 2023
What are the challenges in ensuring access to high-cost medicines?
E-BOOKS
CONTEÚDOS EXCLUSIVOS PARA AUXILIAR EM
SEU TRABALHO
Acesse
bottom of page
